## Abstract ## BACKGROUND Telomere maintenance has been proposed as an essential step for tumor cell immortalization. The objectives of the current study were to investigate the mechanisms implicated in telomere length in colorectal carcinoma (CRC) and to evaluate the prognostic impact of telomere
Telomere length and telomerase subunits as diagnostic and prognostic biomarkers in Barrett carcinoma
✍ Scribed by Ralf Gertler; Dietrich Doll; Matthias Maak; Marcus Feith; Robert Rosenberg
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 171 KB
- Volume
- 112
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
BACKGROUND.
Maintenance of telomeres has been identified as an essential regulator of proliferative capacity and genomic integrity in malignant tumors. The authors evaluated telomere length and telomerase subunits, hTR and hTERT, as prognostic markers in patients with Barrett carcinoma.
METHODS.
Telomere length was measured by Southern blot analysis and hTR expression and hTERT expression by real‐time polymerase chain reaction in both cancer tissue and adjacent noncancerous Barrett mucosa in resection specimens from 46 patients with Barrett carcinoma (International Union Against Cancer [UICC] stages I‐III). The median follow‐up time of the surviving patients was 79 months.
RESULTS.
Cancer tissue expressed more hTERT‐mRNA than noncancerous mucosa (P < .05). Telomere lengths in cancer tissue and in noncancerous mucosa increased with higher pT category (P = .08 and P = .05, respectively). Twenty‐one patients who died of tumor recurrence showed significantly longer telomeres in cancer tissue compared with 25 patients without tumor‐related deaths (P < .05). Telomere length in both cancer tissue and in noncancerous mucosa and the telomere‐length ratio cancer:noncancerous tissue were correlated with overall survival. In multivariate analysis, the telomere‐length ratio proved to be an independent prognostic parameter (P < .02; relative risk of death 3.4; confidence interval, 1.3–8.9). Ten patients with telomere‐length ratios >1.17 had a significantly poorer overall survival compared with 36 patients with telomere‐length ratios ≤1.17 with 5‐year survival rates of 0% and 60%, respectively (P < .02).
CONCLUSIONS.
Telomere length and telomerase subunits were identified as diagnostic and prognostic biomarkers for Barrett carcinoma. Genetic alterations found in adjacent noncancerous mucosa suggested a “field effect” in Barrett carcinoma. Cancer 2008. © 2008 American Cancer Society.
📜 SIMILAR VOLUMES
## Abstract ## Background. Telomerase activity has been found to be associated with many cancers, including head and neck squamous cell carcinoma (HNSCC). We examined the association of telomerase activity with the clinical outcome of patients with HNSCC. ## Methods. A PCR‐based enzyme immunoass
## Abstract ## BACKGROUND The stabilization of telomere lengths by telomerase activation is an important step in carcinogenesis and cell immortalization. Human telomerase reverse transcriptase (hTERT) is the catalytic subunit of this enzyme. The objective of this study was to evaluate the use of r
## Abstract The aim of our study was to prospectively evaluate the potential diagnostic value and clinical applicability of quantitative analysis of telomerase subunits gene expression in urine for noninvasive detection of bladder cancer. Expression levels of human telomerase reverse transcriptase
## Abstract ## BACKGROUND The objectives of this study were to evaluate the diagnostic and prognostic relevance of human telomerase reverse transcriptase (hTERT) detected in situ in patients with nonsmall cell lung carcinoma (NSCLC) and to investigate the possible correlations between hTERT mRNA i